medigraphic.com
Colegio de Medicina Interna de México.

2022, Número 2

<< Anterior Siguiente >>

Med Int Mex 2022; 38 (2)


Obesidad en el ciclo vital femenino y su asociación con trastornos menstruales

Ramírez-Rincón A, Ruiz-Velásquez LM, Mora-Thiriez S, Saldarriaga-Betancur S

Idioma: Español
Referencias bibliográficas: 53
Paginas: 344-354
Archivo PDF: 433.29 Kb.


RESUMEN

La obesidad está estrechamente relacionada con trastornos metabólicos y endocrinos. En la salud de la mujer es de resaltar que la obesidad se vincula con alteraciones hormonales, como anovulación crónica, hiperandrogenismo, infertilidad, incremento en el riesgo cardiovascular, entre otros. En este documento se realiza un abordaje de las alteraciones metabólicas y endocrinas de la mujer con obesidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 2016; 37 (3): 278-316. doi: 10.1210/er.2015-1137.

  2. Ljungvall A, Zimmerman FJ. Bigger bodies: long-term trends and disparities in obesity and body-mass index among U.S. adults, 1960-2008. Soc Sci Med 1982. 2012; 75 (1): 109-19. doi: 10.1016/j.socscimed.2012.03.003.

  3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307 (5): 491-7. doi: 10.1001/jama.2012.39.

  4. Pickett-Blakely O, Uwakwe L, Rashid F. Obesity in Women. Gastroenterol Clin North Am 2016; 45 (2): 317-31. doi: 10.1016/j.gtc.2016.02.008.

  5. Ruiz ÁJ, Aschner PJ, Puerta MF, Alfonso-Cristancho R. Estudio IDEA (International Day for Evaluation of Abdominal Obesity): prevalencia de obesidad abdominal y factores de riesgo asociados en atención primaria en Colombia. Biomédica [Internet] 2012; 32 (4). doi.org/10.7705/biomedica. v32i4.799.

  6. Ministerios de salud y protección social. Estudio ENSIN Colombia 2015 [Internet]. MinSalud; 2015. Disponible en: https://www.minsalud.gov.co/Paginas/Gobierno-presenta- Encuesta-Nacional-de-Situaci%C3%B3n-Nutricionalde- Colombia-ENSIN-2015.aspx

  7. Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes 1979; 3 (1): 57-73.

  8. Grant C, Gallier L, Fahey T, Pearson N, Sarangi J. Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. J Epidemiol Community Health 2000; 54 (9): 709- 13. doi: 10.1136/jech.54.9.709.

  9. Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update 2017; 23 (3): 300-21. doi: 10.1093/humupd/dmw045.

  10. Arem H, Keadle SK, Matthews CE. Meta-physical activity and the search for the truth. Am J Epidemiol 2015; 181 (9): 656-8. doi: 10.1093/aje/kwu472.

  11. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58 (3): 718-25. doi: 10.2337/ db08-1098.

  12. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444 (7121): 881-7. doi: 10.1038/ nature05488.

  13. Item F, Konrad D. Visceral fat and metabolic inflammation: the portal theory revisited: Visceral fat and metabolic inflammation. Obes Rev 2012; 13: 30-9. doi: 10.1111/j.1467- 789X.2012.01035.x.

  14. Votruba SB, Jensen MD. Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol-Endocrinol Metab 2007; 292 (6): E1823-8. doi: 10.1152/ajpendo.00601.2006.

  15. Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014; 156 (1-2): 20-44. doi: 10.1016/j. cell.2013.12.012.

  16. Karastergiou K, Fried SK, Xie H, Lee MJ, Divoux A, Rosencrantz MA, et al. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J Clin Endocrinol Metab 2013; 98 (1): 362-71. doi: 10.1210/jc.2012-2953.

  17. Tobias JH, Steer CD, Vilariňo-Güell C, Brown MA. Effect of an Estrogen receptor-α intron 4 polymorphism on fat mass in 11-year-old children. J Clin Endocrinol Metab 2007; 92 (6): 2286-91. doi: 10.1210/jc.2006-2447.

  18. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992; 55 (5): 950-4. doi: 10.1093/ajcn/55.5.950.

  19. Panotopoulos G, Ruiz JC, Raison J, Guy-Grand B, Basdevant A. Menopause, fat and lean distribution in obese women. Maturitas 1996; 25 (1): 11-9. doi: 10.1016/0378- 5122(96)01119-x.

  20. Svendsen OL, Hassager C, Christiansen C. Age- and menopause- associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995; 44 (3): 369-73. doi: 10.1016/0026-0495(95)90168-x.

  21. Abdulnour J, Doucet É, Brochu M, Lavoie J-M, Strychar I, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause J North Am Menopause Soc 2012; 19 (7): 760-7. doi: 10.1097/ gme.0b013e318240f6f3.

  22. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, et al. Postmenopausal hormone therapy: an endocrine society scientific statement. J Clin Endocrinol Metab 2010; 95 (7 suppl 1): s1-66. doi: 10.1210/jc.2009-2509.

  23. Manson JE, Kaunitz AM. Menopause management — getting clinical care back on track. N Engl J Med 2016; 374 (9): 803-6. doi: 10.1056/NEJMp1514242.

  24. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015; 402: 113-9. doi: 10.1016/j. mce.2014.11.029.

  25. Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A 2001; 98 (20): 11765-70. doi: 10.1073/pnas.201394198.

  26. Schindler AE. Progestogen deficiency and endometrial cancer risk. Maturitas 2009; 62 (4): 334-7. doi: 10.1016/j. maturitas.2008.12.018.

  27. Asarian L, Geary N. Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol 2013; 305 (11): R1215-67. doi: 10.1152/ajpregu.00446.2012.

  28. Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC, Gortmaker SL, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011; 378 (9793): 826- 37. doi: 10.1016/S0140-6736(11)60812-X.

  29. Barr SI, Janelle KC, Prior JC. Energy intakes are higher during the luteal phase of ovulatory menstrual cycles. Am J Clin Nutr. 1995;61(1):39-43. doi: 10.1093/ajcn/61.1.39.

  30. Rock CL, Gorenflo DW, Drewnowski A, Demitrack MA. Nutritional characteristics, eating pathology, and hormonal status in young women. Am J Clin Nutr 1996; 64 (4): 566-71. doi: 10.1093/ajcn/64.4.566.

  31. Brennan IM, Feltrin KL, Nair NS, Hausken T, Little TJ, Gentilcore D, et al. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. Am J Physiol Gastrointest Liver Physiol 2009; 297 (3): G602-10. doi: 10.1152/ajpgi.00051.2009.

  32. Bowen DJ, Grunberg NE. Variations in food preference and consumption across the menstrual cycle. Physiol Behav 1990; 47 (2): 287-91. doi: 10.1016/0031-9384(90)90144-s.

  33. Czaja JA. Ovarian influences on primate food intake: Assessment of progesterone actions. Physiol Behav 1978; 21 (6): 923-8. doi: 10.1016/0031-9384(78)90167-1.

  34. Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, et al. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007; 56 (4): 1051-8. doi: 10.2337/db06-0015.

  35. Rosenbaum M, Pietrobelli A, Vasselli J, Heymsfield S, Leibel R. Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution. Int J Obes 2001; 25 (9): 1365-71. doi: 10.1038/ sj.ijo.0801730.

  36. Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N. Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev 2017; 97 (1): 411-63. doi: 10.1152/physrev.00031.2014.

  37. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: A systematic review and meta-analysis. JAMA 2014; 311 (15): 1536. doi: 10.1001/jama.2014.2269.

  38. Seif MW, Diamond K, Nickkho-Amiry M. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol 2015; 29 (4): 516-27. doi: 10.1016/j.bpobgyn.2014.10.010.

  39. Kleinberg DL, Noel GL, Frantz AG. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 1977; 296 (11): 589-600. doi: 10.1056/ NEJM197703172961103.

  40. Schlechte J, Sherman B, Halmi N, VanGilder J, Chapler F, Dolan K, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study. Endocr Rev 1980; 1 (3): 295-308. doi: 10.1210/edrv-1-3-295.

  41. Gómez F, Reyes FI, Faiman C. Non-puerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med 1977; 62 (5): 648-60. doi: 10.1016/0002-9343(77)90866-x.

  42. Bayrak A, Saadat P, Mor E, Chong L, Paulson RJ, Sokol RZ. Pituitary imaging is indicated for the evaluation of hyperprolactinemia. Fertil Steril 2005; 84 (1): 181-5. doi: 10.1016/j.fertnstert.2005.01.102.

  43. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am 2003; 32 (4): 895-914. doi: 10.1016/s0889-8529(03)00078-1.

  44. Terock J, Hohagen F, Petersen D, Zurowski B. Prolactinomaassociated obesity treated with bupropion and methylphenidate. Ther Adv Psychopharmacol 2013; 3 (3): 177-80. doi: 10.1177/2045125312467345.

  45. Cincotta AH, Meier AH. Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care 1996; 19 (6): 667-70. doi: 10.2337/ diacare.19.6.667.

  46. Basson R. Female sexual dysfunction in hypopituitarism. Lancet 2007; 370 (9589): 737. doi: 10.1016/S0140- 6736(07)61368-3.

  47. Garg M, Brar K, Suryanarayana K. Adult hypopituitarism: Are we missing or is it clinical lethargy? Indian J Endocrinol Metab 2011; 15 (3): 170. doi: 10.4103/2230-8210.83400.

  48. Ascoli P, Cavagnini F. Hypopituitarism. Pituitary 2006; 9 (4): 335-42. doi: 10.1007/s11102-006-0416-5.

  49. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet 2006; 367 (9522): 1605-17. doi: 10.1016/S0140-6736(06)68699-6.

  50. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003; 138 (12): 980-91. doi: 10.7326/0003-4819-138-12-200306170- 00010.

  51. Goadsby Pj. Acromegaly. N Engl J Med 2007; 356 (12): 1274-6. doi: 10.1056/NEJMc070019.

  52. Katznelson L, Atkinson JLD, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 2011; 17 Suppl 4: 1-44. doi: 10.4158/ep.17.s4.1.

  53. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2013; 98 (12): 4565-92. doi: 10.1210/jc.2013-2350.




2020     |     www.medigraphic.com